The Royal Marsden NHS Foundation Trust Breast Unit

ESMO Fellowship Host Institute

Contact person Professor Ian Smith
Address Fulham Road
London
SW3 6JJ
Country

United Kingdom

Contact Tel: +44 207 808 2751 -
Web The Royal Marsden NHS Foundation Trust
Host Institute The Royal Marsden

Fellowship Opportunities

Clinical Research Fellowship

Training Experience Required

Essential:
Proficient in English.
GMC Full registration with a licence to practise.
MB BS or acceptable equivalent.
MRCP or acceptable equivalent.

Experience Essential:
At least two years post graduate training in medical oncology in a recognised Cancer Centre/Unit, and including at least some breast cancer experience.

Skills/Abilities/Knowledge:
Essential: Proficient in written and spoken English.

Other Requirements:
Essential: Flexibility to work across both sites as and when the service requires.

General description

The Royal Marsden NHS Trust, Sutton, Surrey and Fulham Road, London is a postgraduate teaching hospital concerned with diagnosis, treatment and study of patients with cancer. It has a close association with the Institute of Cancer Research which is leading in basic research into the nature and treatment of cancer. Together the two campuses constitute the largest concentration of clinical cancer research in Europe. The medical work of the hospital is organized into multidisciplinary disease oriented units.

Expertise

Professor Ian Smith is Head of the Breast Unit and Professor Stephen Johnston, Dr Mary O’Brien, Dr Charles Swanton, Dr Marina Parton, Dr Nick Turner are Consultant Medical Oncologists on the Unit, supported by an Associate Specialist, Dr Mark Allen. Dr Parton also has responsibilities at nearby Kingston Hospital where the Breast Unit is closely integrated with our own.

The rest of the Unit consists of 3 Medical Oncology Specialist Registrars, 3-4 Clinical Research Fellows, 5 Research Nurses and 4 Clinical Trial co-ordinators/ Data Managers. The Breast Unit has a busy clinical practice and its main research interests are novel therapies, neoadjuvant therapy and molecular markers.

Facilities

Large outpatient clinics and inpatient beds, backed up by full range of diagnostic and imaging facilities. Strong Research links with scientists in the Institute of Cancer Research.